Literature DB >> 15731558

Cerebrovascular disease as a complication of cardiac transplantation.

Robert Belvís1, Joan Martí-Fàbregas, Dolores Cocho, María Dolores García-Bargo, Elisabeth Franquet, Rolando Agudo, Vicenç Brosa, Marta Campreciós, Mireia Puig, Josep Lluis Martí-Vilalta.   

Abstract

BACKGROUND AND OBJECTIVES: To characterize the frequency, risk factors, clinical presentation and etiological subtypes of cerebrovascular diseases (CVD) following cardiac transplantation (CTX).
METHODS: In a retrospective review of our CTX database (period 1984-2002), we assessed demographic data, vascular risk factors, surgery and donor details. We classified ischemic stroke (IS) using the clinical criteria of the Oxfordshire Community Stroke Project and the etiological criteria of the TOAST study. Logistic regression analysis and survival curves were carried out.
RESULTS: CTX was performed in a total of 314 patients (age 46 +/- 14 years, 78% male) and mean follow-up was 54 +/- 57 months. Twenty-two patients (7%) presented CVD: hemorrhagic stroke in 12%, transient ischemic attack in 28% and IS in 60%. CVD were early postoperative (less than 2 weeks) in 20% of patients and late in 80%. The clinical presentation in patients with IS was total anterior circulation (23.1%), partial anterior (38.4%), lacunar (15.4%) and posterior circulation (23.1%), and the etiological classification was large artery atherosclerosis (15.4%), cardioembolism (14.4%), small vessel disease (15.4%), unusual causes (15.4%) and undetermined cause (38.4%). The only independent predictor of CVD was a prior CVD event with an odds ratio of 8.2 (95% CI, 2.2-30.2, p < 0.02). The estimated risk of CVD at 5 years was greater (p < 0.02) in patients with prior CVD (4.1%) than in those without (1.1%).
CONCLUSIONS: CVD are a relatively frequent complication after CTX (7%) and usually occur in the late postoperative phase. CVD prior to transplantation increase the risk of CVD after this procedure. Copyright 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15731558     DOI: 10.1159/000084091

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  8 in total

Review 1.  [Neurological aspects of chronic heart failure].

Authors:  K G Häusler; U Laufs; M Endres
Journal:  Nervenarzt       Date:  2011-06       Impact factor: 1.214

2.  Cerebrovascular complications after heart transplantation.

Authors:  Aída Alejaldre; Raquel Delgado-Mederos; Miguel Ángel Santos; Joan Martí-Fàbregas
Journal:  Curr Cardiol Rev       Date:  2010-08

3.  Interobserver agreement in the trial of org 10172 in acute stroke treatment classification of stroke based on retrospective medical record review.

Authors:  James F Meschia; Kevin M Barrett; Felix Chukwudelunzu; W Mark Brown; L Douglas Case; Brett M Kissela; Robert D Brown; Thomas G Brott; Tammy S Olson; Stephen S Rich; Scott Silliman; Bradford B Worrall
Journal:  J Stroke Cerebrovasc Dis       Date:  2006 Nov-Dec       Impact factor: 2.136

4.  Antithrombotic medication for cardioembolic stroke prevention.

Authors:  M Àngels Font; Jerzy Krupinski; Adrià Arboix
Journal:  Stroke Res Treat       Date:  2011-06-22

Review 5.  Ischemic Stroke after Heart Transplantation.

Authors:  Maurizio Acampa; Pietro Enea Lazzerini; Francesca Guideri; Rossana Tassi; Giuseppe Martini
Journal:  J Stroke       Date:  2016-02-26       Impact factor: 6.967

6.  Clinical Characteristics of Transplant-associated Encephalopathy in Children.

Authors:  Yun Jeong Lee; Mi Sun Yum; Eun Hee Kim; Min Jee Kim; Kyung Mo Kim; Ho Joon Im; Young Hwue Kim; Young Seo Park; Tae Sung Ko
Journal:  J Korean Med Sci       Date:  2017-03       Impact factor: 2.153

Review 7.  Perioperative stroke: pathophysiology and management.

Authors:  Sang-Bae Ko
Journal:  Korean J Anesthesiol       Date:  2018-02-01

8.  Neurologic Complications in Heart Transplant Recipients Readmitted to the Intensive Care Unit.

Authors:  Helin Şahintürk; Beyza Meltem Yurtsever; Özgür Ersoy; Seda Kibaroğlu; Pınar Zeyneloğlu
Journal:  Cureus       Date:  2021-11-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.